跳至主要内容
临床试验/JPRN-UMIN000042695
JPRN-UMIN000042695已完成3 期

A Comparative Clinical Trial for Critical Limb Ischemia with Paclitaxel Coating Balloon Catheter (JLL-LEG). - The JLL-LEG Pivotal Trial

Japan Lifeline Co., Ltd.0 个研究点目标入组 160 人开始时间: 2020年12月9日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Subject who undergoes EVT as a pretreatment for major amputation or who is expected to cannot avoid major amputation even if EVT is performed. (2) Subject with severe heart failure. (3) Subject with untreated severe coronary artery disease. (4) Subject with severe infection. (5) Subject with ulcers on the heel. (6) Subject with inflammation extending to the sole of the foot. (7) Subject with accumulated pus in the wounds. (8) Subject with taking steroids. (9) Subject with albumin value less than 2.5 g/dl. (10) Subject with low ADL (WHO PS score of 4 or more). Except when it is caused by the underlying disease. (11) Subject with ulcers that are unlikely to becaused by lower limb ischemia, because lower limb blood flow is evaluated to be sufficiently by objective blood flow assessment (angiography, echo, etc.). (12) Subject with ulcers caused by primary diseases other than arteriosclerosis such as vasculitis. (13) Subject with major amputation on the contralateral limb. (14) Subject with Rutherford categories 6 on the contralateral limb. (15) Subject with pregnant or possibly pregnant and lactating. (16) Subject with hypersensitivity reaction to aspirin, heparin, clopidogrel or ticlopidine. (17) Subject with a history of contraindications or allergies to contrast agents. However, subject with a history of allergies are excluded when preoperative administration of steroids can prevent symptoms. (18) Subject with bleeding tendency or abnormal blood coagulation, who cannot perform emergency blood transfusion, or who is contraindicated for antiplatelet drugs. (19) Subject with stroke or transient ischemic attack (TIA) within 6 months before preoperative. (20) Subject with treatment history of abdominal aorta within 1 month before preoperative. (21) Subject who have paclitaxel-eluting stents placed on the target limbs within 1 year before preoperative.

研究者

相似试验